Articles scientifiques

Anticancer drug development: moving away from the old habits.

Auteurs : Ades F, Zardavas D, Aftimos P, Awada A
Année : 2014
Journal : Curr Opin Oncol
Volume : 26(3)
Pages : 334-9

High concordance of protein (by IHC), gene (by FISH; HER2 only), and microarray readout (by TargetPrint) of ER, PgR, and HER2: results from the EORTC 10041/BIG 03-04 MINDACT trial.

Auteurs : Viale G, Slaets L, Bogaerts J, Rutgers E, + collaborators (among others :, Piccart-Gebhart M, Cardoso F
Année : 2014
Journal : Ann Oncol
Volume : 25(4)
Pages : 816-23

Belgian Society of Medical oncology (BSMO - task force on breast cancer survivorship)

Auteurs : de Azambuja E, Azim HA, Buisseret L, Langenaeken C, Tkint de Roodenbeke D
Année : 2014
Journal : Belgian J Medical Oncology
Volume : 7(5)
Pages : 142-155

Breast cancer control in China: challenges and opportunities of the use of population-based routine data studies.

Auteurs : Pinto AC, Canário R, Fidalgo P
Année : 2014
Journal : J Thorac Dis
Volume : 6(9)
Pages : 1167-9

A randomized controlled phase II trial of a novel composition of paclitaxel embedded into neutral and cationic lipids targeting tumor endothelial cells in advanced triple-negative breast cancer (TNBC).

Auteurs : Awada A, Bondarenko IN, Bonneterre J, Nowara E, Ferrero JM, Bakshi AV, Wilke C, Piccart-Gebhart M
Année : 2014
Journal : Ann Oncol
Volume : 25(4)
Pages : 824-31

What is your diagnosis ?

Auteurs : de Azambuja E
Année : 2014
Journal : Belgian J Medical Oncology
Volume : 8(1)
Pages : 21-22

Prominent role of cyclic adenosine monophosphate signalling pathway in the sensitivity of (WT)BRAF/(WT)NRAS melanoma cells to vemurafenib.

Auteurs : Krayem M, Journe F, Wiedig M, Morandini R, Sales F, Awada A, Ghanem G
Année : 2014
Journal : Eur. J. Cancer
Volume : 50(7)
Pages : 1310-20

ESO-ESMO 2nd international consensus guidelines for advanced breast cancer (ABC2).

Auteurs : Cardoso F, Costa A, Norton L, Senkus E, Aapro M, André F, Barrios CH, Bergh J, Biganzoli L, Blackwell KL, Cardoso MJ, Cufer T, El Saghir N, Fallowfield L, Fenech D, Francis P, Gelmon K, Giordano SH, Gligorov J, Goldhirsch A, Harbeck N, Houssami N, Hudis C, Kaufman B, Krop I, Kyriakides S, Lin UN, Mayer M, Merjaver SD, Nordström EB, Pagani O, Partridge A, Penault-Llorca F, Piccart-Gebhart M, Rugo H, Sledge G, Thomssen C, + collaborators (among others :, Winer A
Année : 2014
Journal : Breast
Volume : 23(5)
Pages : 489-502

Circulating tumor cells and circulating tumor DNA for precision medicine: dream or reality?

Auteurs : Ignatiadis M, Dawson SJ
Année : 2014
Journal : Ann Oncol
Volume : 25(12)
Pages : 2304-2313

The landscape of medical oncology in Europe by 2020.

Auteurs : de Azambuja E, Ameye L, Paesmans M, Zielinski CC, Piccart-Gebhart M, Preusser M
Année : 2014
Journal : Ann Oncol
Volume : 25(2)
Pages : 525-8

ESO-ESMO 2nd international consensus guidelines for advanced breast cancer (ABC2)†.

Auteurs : Cardoso F, Costa A, Norton L, Senkus E, Aapro M, André F, Barrios CH, Bergh J, Biganzoli L, Blackwell KL, Cardoso MJ, Cufer T, El Saghir N, Fallowfield L, Fenech D, Francis P, Gelmon K, Giordano SH, Gligorov J, Goldhirsch A, Harbeck N, Houssami N, Hudis C, Kaufman B, Krop I, Kyriakides S, Lin UN, Mayer M, Merjaver SD, Nordström EB, Pagani O, Partridge A, Penault-Llorca F, Piccart-Gebhart M, Rugo H, Sledge G, Thomssen C
Année : 2014
Journal : Ann Oncol
Volume : 25(10)
Pages : 1871-88

Clinical validity of circulating tumour cells in patients with metastatic breast cancer: a pooled analysis of individual patient data.

Auteurs : Bidard FC, Peeters DJ, Fehm T, Nolé F, Gisbert-Criado R, Mavroudis D, Grisanti S, Generali D, Garcia-Saenz JA, Stebbing J, Caldas C, Gazzaniga P, Manso L, Zamarchi R, de Lascoiti AF, De Mattos-Arruda L, Ignatiadis M, Lebofsky R, Van Laere SJ, Meier-Stiegen F, Sandri MT, Vidal-Martinez J, Politaki E, Consoli F, Bottini A, Diaz-Rubio E, Krell J, Dawson SJ, Raimondi C, Rutten A, Janni W, Munzone E, Carañana V, Agelaki S, Almici C, Dirix L, Solomayer EF, Zorzino L, Johannes H, Reis-Filho JS, Pantel K, Pierga JY, Michiels S
Année : 2014
Journal : Lancet Oncol
Volume : 15(4)
Pages : 406-14

Molecular biology in medical oncology: diagnosis, prognosis, and precision medicine.

Auteurs : Aftimos P, Barthelemy P, Awada A
Année : 2014
Journal : Discov Med
Volume : 17(92)
Pages : 81-91

Words matter: distinguishing personalized medicine" and "biologically personalized therapeutics"."

Auteurs : Cherny NI, de Vries EG, Emanuel L, Fallowfield L, Francis PA, Gabizon A, Piccart-Gebhart M, Sidransky D, Soussan-Gutman L, Tziraki C
Année : 2014
Journal : J. Natl. Cancer Inst.
Volume : 106(12)

The current and future role of the medical oncologist in the professional care for cancer patients: a position paper by the European Society for Medical Oncology (ESMO).

Auteurs : Popescu RA, Schäfer R, Califano R, Eckert R, Coleman R, Douillard JY, Cervantes A, Casali PG, Sessa C, van Cutsem E, De Vries E, Pavlidis N, Fumasoli K, Wörmann B, Samonigg H, Cascinu S, Cruz Hernández JJ, Howard AJ, Ciardiello F, Stahel RA, Piccart-Gebhart M
Année : 2014
Journal : Ann Oncol
Volume : 25(1)
Pages : 9-15

Luminal B Breast Cancer: Molecular Characterization, Clinical Management, and Future Perspectives.

Auteurs : Ades F, Zardavas D, Bozovic-Spasojevic I, Pugliano L, Fumagalli D, de Azambuja E, Viale G, Sotiriou C, Piccart-Gebhart M
Année : 2014
Journal : J. Clin. Oncol.
Volume : 32(25)
Pages : 2794-803

Incidence and time course of everolimus-related adverse events in postmenopausal women with hormone receptor-positive advanced breast cancer: insights from BOLERO-2.

Auteurs : Rugo HS, Pritchard KI, Gnant M, Noguchi S, Piccart-Gebhart M, Hortobagyi G, Baselga J, Perez A, Geberth M, Csoszi T, Chouinard E, Srimuninnimit V, Puttawibul P, Eakle J, Feng W, Bauly H, El-Hashimy M, Taran T, Burris HA
Année : 2014
Journal : Ann Oncol
Volume : 25(4)
Pages : 808-15

A phase I pharmacokinetics study of lapatinib and tamoxifen in metastatic breast cancer (EORTC 10053 Lapatam study).

Auteurs : Fumoleau P, Koch KM, Brain E, Lokiec F, Rezai K, Awada A, Hayward L, Werutsky G, Bogaerts J, Marréaud S, Cardoso F
Année : 2014
Journal : Breast
Volume : 23(5)
Pages : 663-9

A rare case of prostatic extra gonadal germ cell tumor in a young adult: Review of the literature

Auteurs : Sideris S, Aftimos P, Georgala A, Sirtaine N, Awada A, Gil T
Année : 2014
Journal : J Clin Diagn Res
Volume : 2
Pages : 2

Pathological complete response after neoadjuvant chemotherapy is an independent predictive factor irrespective of simplified breast cancer intrinsic subtypes: a landmark and two-step approach analyses from the EORTC 10994/BIG 1-00 phase III trial.

Auteurs : Bonnefoi H, Litière S, Piccart-Gebhart M, Macgrogan G, Fumoleau P, Brain E, Petit T, Rouanet P, Jassem J, Moldovan C, Bodmer A, Zaman K, Cufer T, Campone M, Luporsi E, Malmström P, Werutsky G, Bogaerts J, Bergh J, Cameron DA
Année : 2014
Journal : Ann Oncol
Volume : 25(6)
Pages : 1128-36